Moreover, MYCN-amplified the Grp3-MB cell lines MB002, Sd425 and D283 and the MYCN-amplified NB cell line Kelly are particularly sensitive to MILCICLIB treatment, evinced by cell cycle arrest and massive apoptosis [829]. The gene discussed is RASGRP3; the disease is neuroblastoma.